510(k) Report

510(k) · Cleared

Cleared

Critiview, Model CRV3

K062977510(k) TraditionalCleared Feb 28, 2007152-day reviewClass II21 CFR 870.2100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Critisense, Ltd. · DPW Flowmeter, Blood, Cardiovascular

Cleared on Feb 28, 2007 as substantially equivalent to K051145 (Critisense, Ltd., 2006) and 1 other predicate after a 152-day review. Its family tree reaches back 2 generations to 2000.

Decided
Feb 28, 2007
Review
152 days
Class
Class II
Product code
DPW
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K992529 (2000). 3 ancestors in all, the oldest K923538 (1993). No later device cites it as a predicate yet.

Other ancestors, by year cleared 1993: 1 other ancestorK992529 · Tissue Spectroscope · Vital Medical, Ltd. · 2000K051145 · Critiview · Critisense, Ltd. · 20061990199520002005
Other ancestors, by generation 1 generation back: 1 other ancestor K051145 · Critiview · Critisense, Ltd. · 2006K992529 · Tissue Spectroscope · Vital Medical, Ltd. · 20000
  1. Root · 2 generations backK992529 Tissue SpectroscopeVital Medical, Ltd. · 2000
  2. 1 generation backK051145 CritiviewCritisense, Ltd. · 2006
  3. This deviceK062977 Critiview, Model CRV3Critisense, Ltd. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K992529Tissue SpectroscopeVital Medical, Ltd.2000—
−1K051145CritiviewCritisense, Ltd.2006—
0 (this device)K062977Critiview, Model CRV3Critisense, Ltd.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
FIG. 1 — Lineage of K062977, 2000–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DPW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DPW device

  1. #1 K251114 FloPatch FP120score 13.7 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051145Critiview
Summary page 1
…Catheter, retention type, balloon accessory (EZL) Device: CritiView Model CRV3 Predicate Devices: CritiView, CritiSense Ltd, K051145 Mallinckrodt - Foley with temperature - K923538 General Device Description: The CritiView device…
Critisense, Ltd.2006—
*K923538Mon-a-Therm Foley Kit
Summary page 1
…CritiView Model CRV3 Predicate Devices: CritiView, CritiSense Ltd, K051145 Mallinckrodt - Foley with temperature - K923538 General Device Description: The CritiView device carries out certain in-vivo, spectroscopic measurements and displays them as…
Mallinckrodt Medical1993—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 5.2 years on median.
  • None of the 3 ancestors has a recall.

How does its category compare?

All DPW devices

DPW Flowmeter, Blood, Cardiovascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · DPW

3in 2025

2007: 12008: 12010: 22011: 42012: 12013: 22015: 32016: 12018: 22019: 32020: 22021: 22022: 32023: 12024: 12025: 32026 (partial year): 2
2007high 4 (2011) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DPW

119in 2025

2011: 89 days median2015: 275 days median2019: 169 days median2022: 136 days median2025: 119 days median
2007high 275 (2015) · low 89 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DPW

1in 2025

2007: 42010: 12012: 12017: 12025: 1
2007high 4 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DPW

6in 2025

2009: 12011: 12013: 32014: 82015: 122016: 12017: 22019: 32020: 42021: 62022: 12023: 22024: 42025: 6
2007high 12 (2015) · low 0 (2007)2025

MAUDE reports naming product code DPW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—40
20081—00
20090—01
20102—10
201148901
20121—10
20132—03
20140—08
20153275012
20161—01
20170—12
20182—00
2019316903
20202—04
20212—06
2022313601
20231—02
20241—04
2025311916
20262—0—

What is it indicated for?

The CritiView Device is indicated for in-vivo monitoring of changes in NADH redox state and microvascular perfusion in tissue. Changes in the measured parameters--blood flow change, blood volume change, and NADH concentration change-- provide information on tissue metabolic activity. Tissues which may be monitored are: brain, liver, kidney, intestine, testis, skin, and urethra. Note that heart may not be used as the heart beating motion may not provide a…

Read the full statement (235 words)

The CritiView Device is indicated for in-vivo monitoring of changes in NADH redox state and microvascular perfusion in tissue. Changes in the measured parameters--blood flow change, blood volume change, and NADH concentration change-- provide information on tissue metabolic activity.

Tissues which may be monitored are: brain, liver, kidney, intestine, testis, skin, and urethra. Note that heart may not be used as the heart beating motion may not provide a reliable probe contact surface.

Duration of Use:

The CritiView has two probes--a pencil style probe and a Foley catheter probe-- which are in contact with the tissue to be measured / monitored. The optical portion of the probe (device) may be used continuously for up to eight (8) hours per twenty-four (24) hour period.

The Foley catheter can be left in place up to five (5) days.

Patient Population:

Pencil Style Probe: Neonate/infant, pediatric, and adult

Foley Catheter Probe: Hospitalized adults who are clinically indicated for a Foley catheter use.

Environment of use:

Hospital - OR, ICU, Emergency Departments, High Dependency Units Institutions

Contraindications:

The Criti View should not be used on people that are hypersensitive to UV radiation. The device should not be used on patients taking photosensitizing drugs.

When monitoring the urethral wall tissue the device should not be used on patients with urinary tract or bladder infection or in any case when the patient clinical condition prevents the use of a Foley catheter.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062977: Critiview, Model CRV3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062977

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026